Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Net Cash Flow (2025 - 2026)

MDxHealth has reported Net Cash Flow over the past 2 years, most recently at $14.1 million for Q1 2026.

  • For Q1 2026, Net Cash Flow fell 25.14% year-over-year to $14.1 million; the TTM value through Mar 2026 reached $33.0 million, up 74.86%, while the annual FY2025 figure was -$17.8 million, 197.55% down from the prior year.
  • Net Cash Flow was $14.1 million for Q1 2026 at MDxHealth, down from $18.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $18.9 million in Q1 2025 and bottomed at $14.1 million in Q1 2026.